These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
96 related articles for article (PubMed ID: 27039250)
21. Synthesis of novel GABA uptake inhibitors. Part 6: preparation and evaluation of N-Omega asymmetrically substituted nipecotic acid derivatives. Andersen KE; Lau J; Lundt BF; Petersen H; Huusfeldt PO; Suzdak PD; Swedberg MD Bioorg Med Chem; 2001 Nov; 9(11):2773-85. PubMed ID: 11597457 [TBL] [Abstract][Full Text] [Related]
22. Synthesis and GABA uptake inhibitory properties of 6-aryl iminoxymethyl substituted nipecotic acids. N'goka V; Stenbøl TB; Krogsgaard-Larsen P; Schlewer G Eur J Med Chem; 2004 Oct; 39(10):889-95. PubMed ID: 15464623 [TBL] [Abstract][Full Text] [Related]
23. Syntheses and GABA uptake properties of 6-ether- and 6-enol ether-substituted nipecotic acids. N'Goka V; Bissantz C; Bisel P; Stenbøl TB; Krogsgaard-Larsen P; Schlewer G Eur J Med Chem; 2004 Jul; 39(7):633-8. PubMed ID: 15236844 [TBL] [Abstract][Full Text] [Related]
24. Synthesis and biological evaluation of new derivatives of 2-substituted 4-hydroxybutanamides as GABA uptake inhibitors. Kulig K; Więckowski K; Więckowska A; Gajda J; Pochwat B; Höfner GC; Wanner KT; Malawska B Eur J Med Chem; 2011 Jan; 46(1):183-90. PubMed ID: 21111516 [TBL] [Abstract][Full Text] [Related]
25. GABA uptake inhibitors containing mono- and diarylmethoxyalkyl N-substituents. Falch E; Krogsgaard-Larsen P Drug Des Deliv; 1989 May; 4(3):205-15. PubMed ID: 2535204 [TBL] [Abstract][Full Text] [Related]
26. Development of imidazole alkanoic acids as mGAT3 selective GABA uptake inhibitors. Hack S; Wörlein B; Höfner G; Pabel J; Wanner KT Eur J Med Chem; 2011 May; 46(5):1483-98. PubMed ID: 21353350 [TBL] [Abstract][Full Text] [Related]
27. Nipecotic acid as potential lead molecule for the development of GABA uptake inhibitors; structural insights and design strategies. Singh K; Kumar P; Bhatia R; Mehta V; Kumar B; Akhtar MJ Eur J Med Chem; 2022 Apr; 234():114269. PubMed ID: 35306287 [TBL] [Abstract][Full Text] [Related]
28. Development of tricyclic N-benzyl-4-hydroxybutanamide derivatives as inhibitors of GABA transporters mGAT1-4 with anticonvulsant, antinociceptive, and antidepressant activity. Zaręba P; Sałat K; Höfner GC; Łątka K; Bajda M; Latacz G; Kotniewicz K; Rapacz A; Podkowa A; Maj M; Jóźwiak K; Filipek B; Wanner KT; Malawska B; Kulig K Eur J Med Chem; 2021 Oct; 221():113512. PubMed ID: 34015586 [TBL] [Abstract][Full Text] [Related]
29. Novel mouse GABA uptake inhibitors with enhanced inhibitory activity toward mGAT3/4 and their effect on pain threshold in mice. Zaręba P; Gryzło B; Malawska K; Sałat K; Höfner GC; Nowaczyk A; Fijałkowski Ł; Rapacz A; Podkowa A; Furgała A; Żmudzki P; Wanner KT; Malawska B; Kulig K Eur J Med Chem; 2020 Feb; 188():111920. PubMed ID: 31901745 [TBL] [Abstract][Full Text] [Related]
30. Synthesis of novel GABA uptake inhibitors. 3. Diaryloxime and diarylvinyl ether derivatives of nipecotic acid and guvacine as anticonvulsant agents. Knutsen LJ; Andersen KE; Lau J; Lundt BF; Henry RF; Morton HE; Naerum L; Petersen H; Stephensen H; Suzdak PD; Swedberg MD; Thomsen C; Sørensen PO J Med Chem; 1999 Sep; 42(18):3447-62. PubMed ID: 10479278 [TBL] [Abstract][Full Text] [Related]
31. Synthesis of novel GABA uptake inhibitors. 4. Bioisosteric transformation and successive optimization of known GABA uptake inhibitors leading to a series of potent anticonvulsant drug candidates. Andersen KE; Sørensen JL; Huusfeldt PO; Knutsen LJ; Lau J; Lundt BF; Petersen H; Suzdak PD; Swedberg MD J Med Chem; 1999 Oct; 42(21):4281-91. PubMed ID: 10543872 [TBL] [Abstract][Full Text] [Related]
32. Library screening by means of mass spectrometry (MS) binding assays-exemplarily demonstrated for a pseudostatic library addressing γ-aminobutyric acid (GABA) transporter 1 (GAT1). Sindelar M; Wanner KT ChemMedChem; 2012 Sep; 7(9):1678-90. PubMed ID: 22689508 [TBL] [Abstract][Full Text] [Related]
33. 2-Substituted 4-hydroxybutanamides as potential inhibitors of γ-aminobutyric acid transporters mGAT1-mGAT4: synthesis and biological evaluation. Kowalczyk P; Sałat K; Höfner GC; Guzior N; Filipek B; Wanner KT; Kulig K Bioorg Med Chem; 2013 Sep; 21(17):5154-67. PubMed ID: 23859778 [TBL] [Abstract][Full Text] [Related]
34. Altered gene expression in frontal cortex and midbrain of 3,4-methylenedioxymethamphetamine (MDMA) treated mice: differential regulation of GABA transporter subtypes. Peng W; Simantov R J Neurosci Res; 2003 Apr; 72(2):250-8. PubMed ID: 12672000 [TBL] [Abstract][Full Text] [Related]
35. Development of New Photoswitchable Azobenzene Based γ-Aminobutyric Acid (GABA) Uptake Inhibitors with Distinctly Enhanced Potency upon Photoactivation. Lutz T; Wein T; Höfner G; Pabel J; Eder M; Dine J; Wanner KT J Med Chem; 2018 Jul; 61(14):6211-6235. PubMed ID: 29924931 [TBL] [Abstract][Full Text] [Related]
36. Identification of the First Highly Subtype-Selective Inhibitor of Human GABA Transporter GAT3. Damgaard M; Al-Khawaja A; Vogensen SB; Jurik A; Sijm M; Lie ME; Bæk MI; Rosenthal E; Jensen AA; Ecker GF; Frølund B; Wellendorph P; Clausen RP ACS Chem Neurosci; 2015 Sep; 6(9):1591-9. PubMed ID: 26154082 [TBL] [Abstract][Full Text] [Related]
37. Synthesis, stability, and pharmacological evaluation of nipecotic acid prodrugs. Bonina FP; Arenare L; Palagiano F; Saija A; Nava F; Trombetta D; de Caprariis P J Pharm Sci; 1999 May; 88(5):561-7. PubMed ID: 10229650 [TBL] [Abstract][Full Text] [Related]
38. Synthesis and pharmacological properties of new GABA uptake inhibitors. Sałat K; Więckowska A; Więckowski K; Höfner GC; Kamiński J; Wanner KT; Malawska B; Filipek B; Kulig K Pharmacol Rep; 2012; 64(4):817-33. PubMed ID: 23087134 [TBL] [Abstract][Full Text] [Related]
39. Synthesis of N-substituted acyclic β-amino acids and their investigation as GABA uptake inhibitors. Sitka I; Allmendinger L; Fülep G; Höfner G; Wanner KT Eur J Med Chem; 2013 Jul; 65():487-99. PubMed ID: 23770450 [TBL] [Abstract][Full Text] [Related]